TG Therapeutics' Q3 earnings missed EPS expectations despite Briumvi's revenue growth. See why TGTX stock is a Buy.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today reported its financial and operating results ...

The clinical trial included each University of Oklahoma Medical Center patient who was discharged with at-home IV infusion needs and who agreed to participate. The trial began in March.

Additionally, Briumvi is projected to become a leading product in the intravenous anti-CD20 market within five years, with potential cannibalization from Ocrevus’ subcutaneous formulation. The survey ...

As recovery efforts at the North Carolina plant hit by Hurricane Helene move at an “encouraging pace,” Baxter International is laying out new details on a sweeping importation plan to help ...

Oct 17 (Reuters) - Baxter International (BAX.N), opens new tab said on Thursday it will import 18,000 tons of intravenous products from its newly cleared international plants to the U.S. by the ...

A shortage of IV fluid in the wake of Hurricane Helene is shining a spotlight on the fragility and vulnerability of the country’s medical supply chain. Hospitals were left scrambling after the ...

PHOENIX (AZFamily) — Banner Health, Arizona’s largest health care system, is halting some elective surgeries due to a nationwide IV fluid shortage. Baxter International, the leading supplier ...

With the largest U.S. producer of intravenous fluids still incapacitated by severe flooding damage in North Carolina, government agencies have invoked the Defense Production Act. The purpose ...

A new firmware update has arrived for the Sony A7 IV, adding new features and quality-of-life improvements.

Ocrevus is a medicine commonly used to treat primary progressive MS, but it can take up to four hours to receive intravenously. A new version called “Ocrevus Zunovo” was recently approved by ...

Hurricane Helene flooding shut down a medical supply manufacturer, causing a nationwide shortage of IV fluids, but Cincinnati hospitals say that they haven't canceled or delayed care as a result.